Home NDC 58962-010 Vamousse Pro Lice Treatment
Product NDC 58962-010
11-digit product format 589620010
Labeler code 58962
Product ID 58962-010_30952fd3-fc37-4332-af58-0dca8945ee61
Type HUMAN OTC DRUG
Nonproprietary name SODIUM CHLORIDE
Dosage form LIQUID
Route TOPICAL
Labeler Tyra Tech, Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2015-09-25
Marketing end 0000-00-00
Substance SODIUM CHLORIDE
Active strength 2 [hp_X]/mL
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 58962-010-01 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 58962-010-01 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 58962-010-01 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 58962-010-01 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 58962-010-01 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 58962-010-01 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 58962-010-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 58962-010-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 58962-010-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 58962-010-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 58962-010-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 58962-010-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 58962-010-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 58962-010-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 58962-010-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 58962-010-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 58962-010-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 58962-010-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 58962-010-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 58962-010-01 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 58962-010-01 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 58962-010-01 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 58962-010-01 Vamousse Pro Lice Treatment 946 mL in 1 BOTTLE LIQUID 946 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded SODIUM CHLORIDE ACTIVE INGREDIENT 451W47IQ8X VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 SODIUM CATION ACTIVE MOIETY LYR4M0NH37 VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 BUTYL LACTATE INACTIVE INGREDIENT 0UI63W814U VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 CETRIMONIUM CHLORIDE INACTIVE INGREDIENT UC9PE95IBP VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 DMDM HYDANTOIN INACTIVE INGREDIENT BYR0546TOW VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 GERANIOL INACTIVE INGREDIENT L837108USY VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 ISOPROPYL MYRISTATE INACTIVE INGREDIENT 0RE8K4LNJS VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 MAGNESIUM CHLORIDE INACTIVE INGREDIENT 02F3473H9O VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 MAGNESIUM NITRATE INACTIVE INGREDIENT 77CBG3UN78 VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 METHYLCHLOROISOTHIAZOLINONE INACTIVE INGREDIENT DEL7T5QRPN VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 METHYLISOTHIAZOLINONE INACTIVE INGREDIENT 229D0E1QFA VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 PEPPERMINT OIL INACTIVE INGREDIENT AV092KU4JH VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 TRIETHYL CITRATE INACTIVE INGREDIENT 8Z96QXD6UM VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 58962-010 VAMOUSSE PRO LICE TREATMENT (SODIUM CHLORIDE) LIQUID [TYRA TECH, INC.] 1 Legacy NDC, 1 package rows 20151001_55d73c20-7ef5-42e9-93f3-73e9b4f5a0ce.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 58962-010-01 58962001001 946 mL in 1 BOTTLE 946 ml Historical